Leidos Australia signs MOU with Monash University
MELBOURNE, Australia, 29 November, 2017 – Leidos Australia and Monash University have signed a Memorandum of Understanding (MOU) to collaborate on research and development (R&D) at the Monash Institute of Medical Engineering (MIME). The MOU was signed by Director of MIME, Professor Jeffrey V. Rosenfeld AM, OBE and Leidos Australia Technical Director, Dan Brewer.
The MIME fosters and coordinates translational medtech research across Monash University faculties, partner hospitals and collaborating medical research institutions. The clinician-led research programs focus on major clinical and health system needs, and integrate expertise from across engineering, information technology, science, biomedical and clinical research to develop new devices, diagnostics, therapeutics, delivery systems, and clinical tools.
MIME Director, Professor Jeffrey V. Rosenfeld AM, OBE welcomed the MOU with Leidos Australia. “It will foster the development of new technology and IT solutions for human health problems,” he said. “University-industry collaboration is an important goal to create new opportunities for Australian innovation to reach the marketplace,”
Leidos Australia Technical Director, Dan Brewer added, “Health is a key area for Leidos globally and as we continue to grow domestically, we will be looking to further develop our range of capabilities in this area.”
The MOU will see Leidos Australia and the MIME collaborate on future R&D with the initial contribution including the funding of a PhD research student.